Results 131 to 140 of about 12,502 (244)

An In Vitro Investigation of the Antiproliferative and Antimetastatic Effects of Levosimendan: Potential Drug Repurposing for Cervical Cancer

open access: yesCurrent Issues in Molecular Biology
Cervical cancer presents a significant challenge to the global health of women. Despite substantial advances in human papillomavirus (HPV)-related cervical cancer vaccines, non-HPV-related cervical cancer is still waiting novel therapeutic options.
Zsuzsanna Schelz   +4 more
doaj   +1 more source

Investigations for the mechanism of action of novel positive inotropic agents [PDF]

open access: yes, 2017
Az akut szívelégtelenség mortalitása a fejlődő farmakológiai és eszközös kezelés ellenére magas, sőt a Ca2+-mobilizáló inotróp szerek adverz hatásúak a hosszú távú túlélésre.
Nagy, László
core  

Possibilities of using levosimendan in patients with idiopathic pulmonary hypertension

open access: yesТерапевтический архив, 2012
Aim. To evaluate the efficiency and safety of intravenous infusion of levosimendan in patients with idiopathic pulmonary hypertension (IPH) and its clinical, hemodynamic, and neurohumoral effects. Subjects and methods. The study included 9 patients (mean
T V Martyniuk   +4 more
doaj  

Lupus myocarditis. Case report [PDF]

open access: yes, 2005
Myocarditis is one of the many possible forms of cardiac involvement in systemic lupus erythematosus. Its clinical presentation ranges from asymptomatic patients with self-limited disease to fulminant heart failure that can lead to death.
Campos, M   +9 more
core  

Levosimendan.

open access: yesIndian pediatrics, 2010
Shrishu R, Kamath   +2 more
openaire   +3 more sources

Levosimendan vs. Intra-Aortic Balloon Pump in Coronary Artery Bypass Grafting: A Meta-Analysis. [PDF]

open access: yesBraz J Cardiovasc Surg
Wang Y   +6 more
europepmc   +1 more source

Milrinone and levosimendan improve microvascular perfusion in septic rats: a randomized, placebo-controlled trial. [PDF]

open access: yesIntensive Care Med Exp
Marcus C   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy